A pioneer in the field of silicones for personal care products, Shin-Etsu Silicones of America, Inc. recently announced the hiring of Marie Capozzi as a regional sales manager to expand the company’s presence at key accounts and accelerate growth in the personal care and cosmetics market.
Capozzi received her Bachelor of Science degree in biology from Fairleigh Dickinson University and has since cultivated a reputation as a tenacious business development leader with a broad background in cosmetic sales. Notably, she has developed key relationships with major accounts, while representing industry leaders such as Sensient Technologies Corp., Dow Corning Corp., and, most recently, EES Cosmetic Solutions. Capozzi will utilize Shin-Etsu’s extensive tool kit of innovative sensory solutions to enhance specialty products targeting the personal care, cosmetics, and hair care consumer.
Capozzi joins the SESA cosmetics team at their 14,000 sq. ft., state-of-the-art cosmetic application laboratory – strategically located in Paramus, New Jersey, which will allow her to be closer to many of its strategic customers based in New York and New Jersey. She will augment the sales team of Ginny Powell, An-li Quo, and Mike Gerlock to deliver innovative solutions to strategic customers in the personal care and cosmetics industry.
According to Capozzi, “My goal is to further advance SESA’s ability to go beyond basic cosmetic silicone solutions to offer formulators more innovative sensorial benefits across a wide variety of product applications for our key personal and hair care market accounts.”
Repêchage, the pioneers in seaweed-based skin care, launched the new Repêchage Triple Action Peptide Serum and revealed a new design and logo at this year’s International Esthetics, Cosmetics, & Spa Conference (IECSC) at the Jacob Javits Convention Center in New York City, New York.
The Repêchage Triple Action Peptide Serum is the latest in advanced skin care science and natural ingredients. Using powerful peptide and seaweed actives featured in the best-selling, award-winning, and professionally-inspired Repêchage Triple Action Peptide Mask, this new serum does it all by hydrating, brightening, and firming. Fans loved how the Triple Action Peptide Mask helped to revive their complexion and asked for a more intensive treatment.
Now, they can add the Repêchage Triple Action Peptide Serum, suitable for the face, neck, and décolleté, to their daily routine to see a youthful glow day and night. Repêchage also unveiled their new logo, launched in January 2019, and a brand new look for the seaweed-based skin care company.
In addition, show attendees gathered to experience seaweed-based facial treatments, including the Repêchage Peel and Glow Facial. This unique treatment features the Biolight Luminex Mask, a professional hybrid peel treatment with alpha hydroxy acids, Kaolin clay, and seaweed extracts to exfoliate, deep cleanse, and hydrate. Following this treatment is the Triple Action Peptide Mask, an easy-to-apply sheet mask based on age-defying peptides and pure laminaria digitata seaweed extracts for hydrating, firming, and brightening.
Show attendees also experienced signature treatments, such as the Repêchage Seaweed Facial based on pure, sustainably harvested laminaria digitata seaweed extract to provide a soothing and cooling treatment that leaves skin clean, hydrated, and glowing.
The Global Wellness Summit (GWS), the foremost gathering of international leaders in the 4 trillion global wellness economy, announced that Irene Forte, wellness director for Rocco Forte Hotels and daughter of Sir Rocco Forte, British hotelier and philanthropist, will join its advisory board. Forte oversees the wellness strategy and offerings for the 14 Rocco Forte Hotels, has just launched Irene Forte Skincare, and has won awards for her achievements as a rising young entrepreneur. Forte will be instrumental in helping the GWS address the powerhouse demographic in the wellness industry: millennials.
“It’s with great pleasure that I welcome Irene to our board,” said Susie Ellis, GWS chairman and CEO. “We’re a conference devoted to the business of wellness and she will bring invaluable expertise to help ensure that our organization reflects the very future of this industry – millennials and even younger generations. With millennials representing the first wellness generation and as the age demographic that will have the highest spending power by 2025, Irene will help us stay relevant and keep evolving toward the next-generation wellness consumer.”
Candela Corporation, a leading global medical aesthetic device company, announced the publication of the largest study of infants and babies treated with a laser for birthmarks, port wine stains, and other vascular related skin conditions on the face and body. Roy Geronemus, M.D., a world authority on the treatment of laser-based vascular anomalies at Laser & Skin Surgery Center of New York, treated a total of 197 infants and babies with the Vbeam laser in an office setting without the need for anesthesia or surgery. The results of these Vbeam treatments are shared in Geronemus’ study publication titled “Pulsed Dye Laser Treatment of Port-Wine Stains in Infancy Without the Need for General Anesthesia.” Published in the April 2019 issue of the Journal of the American Medical Association-Dermatology, the study results include 26 percent of the patients experiencing complete clearing and 41% having greater than 75% improvement, with no cases of scarring or pigmentary change.
The ability to treat pediatric patients without invasive surgery or anesthesia presents a new therapeutic frontier, especially given FDA warnings around the potential adverse effects of using general anesthetic and sedation drugs on children younger than three years old.
“Because of the tolerability of the Vbeam laser, we are able to provide infants and children with treatment without having to put them under general anesthesia,” said Geronemus. Addressing the developmental impact of early therapy, Geronemus adds, “Treating these skin conditions early on avoids the physical and psychological impact of having a vascular birthmark on the face and body as children develop. In some cases, patients were treated within days of being born and, in many cases, we saw complete or near clearance.”
The 595 nanometer Vbeam laser’s dynamic cooling spray feature allows for maximum versatility and epidermal protection, allowing Geronemus to make this treatment safe for all pediatric patients treated. Data demonstrated that treating before the age of one leads to a more complete response rate and the highest rate of clearance among any age group.
“My son Brody started his Vbeam treatments with Dr. Geronemus at seven-weeks-old and, after just three treatments, the birthmark on his right cheek is almost completely gone,” said Brittany Schorr, mother of Brody Schorr. “People who knew he had the birthmark couldn’t believe it and those who didn’t know he had it will never know he did.”
“We have many families that are looking to improve their child’s life with these treatments that help address birthmarks or other vascular formations. My primary referral for these families is Dr. Geronemus,” said Dr. Linda Rozell-Shannon, president and founder of the Vascular Birthmarks Foundation. “There are specific parameters around using lasers on infants and children and Dr. Geronemus not only follows the latest protocols available but also has seen the most clearance using the Vbeam laser system for these specific cases.”
The Vbeam pulsed dye laser (PDL) is considered the gold-standard for the treatment of port wine stains and vascular anomalies in infants and children, as well as adults. Candela recently introduced the Vbeam Prima laser system to the market, representing the latest innovation in 30 years of clinical leadership for the Vbeam franchise.
“The introduction of the Vbeam Prima laser and our partnership with Dr. Roy Geronemus demonstrates Candela’s commitment to helping change lives,” said Geoffrey Crouse, chief executive officer of Candela. “We are honored to have a partner like Dr. Geronemus who is utilizing Candela’s innovative solutions and breakthrough technologies to help improve the overall quality of life for infants and children. We are thrilled with the published outcomes of his recent study using the Vbeam laser system.”
New technologies and sustainability are causing disruption in the cosmetic and personal care industry. Cosmetic brands and ingredient firms are investing in a raft of green initiatives, while technology is influencing raw materials, production processes, and distribution. Such developments will be featured in the next Sustainable Cosmetics Summit. The tenth North American edition of the executive summit will be hosted in New York May 8 through 10. Packaging pollution has become a major environmental issue for cosmetic and consumer goods industries, with about 300 million tons of plastic waste generated each year.
Andrew Dent, executive vice president of Material Connexion will host a workshop on reducing packaging impacts. Highlighting industry best practices, he will guide cosmetic and personal care brands on how to make their packaging more sustainable. Shane Wolf, general manager of Seed Phytonutrients, will show how the brand is using novel packaging made from post-consumer paper. Launched on Earth Day 2018, Seed Phytonutrients are marketed as farm-to-bottle beauty products, as the company is sourcing organic ingredients directly from American farmers. Aveda has been implementing green initiatives since its formation in 1978. Melissa Chelminiak will give some insights into how it is addressing its environmental and social impacts. The company has won many awards (including Sustainability Leadership at 2017 Sustainable Beauty Awards) in recognition for programs involving ethical sourcing, renewable energy, product design, and responsible packaging. Other topics covered in the opening sessions includes, regenerative agriculture, methodologies to measure impacts, social risks in supply chains, and retailing case study.
New technologies are having a disruptive influence on production, processing, and traceability of ingredients, as well as marketing of finished products. An update will be given on how plant cell technology is creating novel actives, as well as sustainable processing methods. Philip Prather from Down Under Enterprises will use Australian sandalwood as an example on how technology is being used to provide traceability for raw materials. Another speaker will discuss the opportunities provided by artificial intelligence; other topics include mobile apps for sustainable cosmetics, social media marketing success stories, and marketing implications of new technologies.
Green materials continue to make headway into cosmetic and personal care products, however, there are some concerns about the long-term implications. Serena Pozza from the Ellen MacArthur Foundation will discuss the role of such materials in a circular economy. How can existing personal care ingredients be adapted for repeat use? How can truly sustainable chemicals be created? Dr. Ellen Kamhi will give an update on the growing array of natural ingredients used in functional skin care products. Other speakers will discuss new materials from food side streams, natural ingredients for hair care products, and innovating with green materials.
Myriad Genetics Inc., a global leader in personalized medicine, announced that the Medicare administrative contractor Palmetto GBA MolDx has issued a final local coverage determination (LCD) for the myPath Melanoma test to help physicians provide a definitive diagnosis when a suspicious skin lesion is equivocal based upon histopathology.
“We are excited that Palmetto has reviewed the extensive clinical dossier for the myPath Melanoma test and decided to cover the test for Medicare patients,” said Vicki Fish, vice president of dermatology at Myriad Genetics. “We look forward to making the myPath Melanoma test accessible to more patients so that they can obtain a definitive diagnosis and receive appropriate treatment and better health outcomes.”
Melanoma is one of the fastest growing cancers in the United States and can strike people of all ages, races, and skin types. More than one million skin biopsies are performed annually and approximately 15 percent of patients have an equivocal skin lesion. The myPath Melanoma test analyzes 23 genes and has proven to be highly accurate in multiple studies at distinguishing melanoma from benign moles.
“There is strong demand among physicians for an objective genetic test to be used as an adjunct to historical approaches for diagnosis,” said Loren Clarke, M.D., board-certified dermatopathologist and medical director of dermatology at Myriad Genetics. “The myPath Melanoma test has enormous potential to help patients because an appropriate treatment plan begins with an accurate and definitive diagnosis.”
Sierra Sage Herbs, the parent company of the all-natural brand, Green Goo, is proud to announce the launch of a new, plant-based, full-spectrum hemp body care brand called Good Goo. Derived from the same ideals that define Green Goo products – a time-honored infusion process, high-quality ingredients, and purposeful formulations – Good Goo full-spectrum hemp products are created by mindfully selecting only plant-based ingredients and slowly infusing the whole plants in enriching oils.
“Green Goo and Good Goo are definitely complementary brands and our commitment to quality manufacturing, ingredients, and processes remains the same,” said Green Goo and Good Goo CEO and co-owner, Jodi Scott. “Whereas Green Goo products are perhaps more aligned with an active, on-the-go, portable lifestyle, with Good Goo we really wanted to create a product line that was more focused on restorative, balancing, reflective self-care.”
The organic, full-spectrum hemp oil used in Good Goo products undergoes several levels of testing, from soil to final product, to ensure a high standard of purity, legality, and reliable CBD content. Good Goo uses patented methods and truly full-spectrum hemp oil that is not dependent on the use of alcohol, carbon dioxide, or other solvents for extraction. The organic CBD used in Good Goo products is grown and produced in the United States.
Grammy, Emmy, and Tony award-winning songstress Cyndi Lauper is well known for her work on Broadway and chart-topping hits including “Girls Just Want to Have Fun” and “Time after Time,” but what you may not know is that she also lives with plaque psoriasis, an immune-mediated disease which causes skin cells to grow at an abnormally fast rate resulting in raised, dry plaques usually covered by silvery or white scales.
Lauper’s plaque psoriasis first appeared on her scalp and eventually spread to her arms, legs, and torso. She sought treatment from various physicians and tried home remedies that worked at first, but did not provide the long-term results she wanted. In 2015, when her psoriasis was at its worst, Lauper was scheduled to appear on television to promote the United Kingdom premier of her Broadway show, Kinky Boots. On the day of the interview, her disease was flaring so severely she had to airbrush her skin to hide her psoriasis. This was the moment Lauper realized she needed to seek treatment.
Lauper made an appointment with a dermatologist specializing in psoriasis who helped her find a treatment that has been working for her. Since starting treatment, her psoriasis symptoms have improved and she is comfortable showing her skin and performing on stage again.
Lauper’s personal experience with psoriasis taught her how important it is for clients to advocate for themselves, especially if their current treatment is not working, which is why she partnered with Novartis on the SEE ME campaign. Through the campaign, Lauper has become an advocate for the psoriasis community and encourages those struggling with the disease to speak to a skin care professional about a treatment plan that works for them. Her song “Hope,” released in 2017, was inspired by the perseverance of the psoriasis community and was written to give a voice to those struggling with the condition.
Visit seemetoknow.com to learn more about treatment, hear Lauper’s story, watch the music video, and learn about other inspiring people living with psoriasis.
The International SPA Association (ISPA) is teaming up with Beauty Changes Lives to introduce the ISPA Scholarship. Generously sponsored by ISPA, the scholarship will fund eight $1,000 tuition awards to students enrolled in an aesthetics, makeup, special effects makeup, or massage therapy program at an accredited school. Beauty Changes Lives will be accepting applications from March 1 through April 30, 2019.
The ISPA Scholarship raises awareness of spa employers’ soaring demand for qualified professionals. The 2018 ISPA Spa Workforce Study commissioned by ISPA Foundation and conducted by Pricewaterhouse Coopers found nearly 33,000 job openings in the spa industry. The study findings helped inspire the Get Your Dream Job campaign, a national coalition of spas, salons, and associations led by ISPA and Beauty Changes Lives. “With over 30,000 open positions within the spa industry, attracting new professionals to the industry is a top priority for the International SPA Association. We are delighted to offer the ISPA Scholarship and further our partnership with the Get Your Dream Job campaign,” said Lynne McNees, president of ISPA.
The ISPA Scholarship application consists of two steps. First, students must upload a three- to five-minute video showing the applicant applying an aesthetics treatment, massage therapy technique, or makeup application. In addition, applicants are required to describe why they love aesthetics, massage therapy, or makeup, why they chose a spa career, and how working in the spa industry will fulfill their passion.
“The addition of the ISPA Scholarship extends Beauty Changes Lives’ scholarship offerings into the spa sector,” said Lynelle Lynch, president of the Beauty Changes Lives Foundation. “We are honored to offer this scholarship to aspiring spa professionals.”
The Horst M. Rechelbacher Foundation is introducing two Beauty Changes Lives scholarships honoring the late Horst Rechelbacher’s legacy of consciousness, care, and compassion for beauty professionals, clients, and the planet. The Sustainable Success advanced cosmetology scholarship and Oncology Skincare scholarship for licensed aestheticians will collectively offer $50,000 in scholarship awards. Administered by the Beauty Changes Lives Foundation, the scholarships will be awarded in spring, summer, and fall of 2019. Applications for the spring Sustainable Success and Oncology Skincare scholarships will be accepted March 1 to April 30, 2019.
Offered to licensed cosmetologists enrolled in an accredited cosmetology program, the Sustainable Success scholarship will award $22,000 in tuition awards. Two tuition scholarships in the amount of $2,200 will be awarded in the inaugural spring competition and eight additional awards of $2,200 will be awarded in summer (four) and fall (four) competitions. Applicants must submit an online application and prepare a three- to five-minute video sharing why they selected a career in cosmetology and their personal perspective on success.
Offered to licensed aestheticians seeking to better serve individuals affected by cancer, the Oncology Skincare scholarship will award $28,000 in tuition awards. Four tuition scholarships in the amount of $2,000 will be awarded in the inaugural spring competition and 10 additional awards will be awarded in summer (five) and fall (five) competitions. The scholarship was inspired by the Oncology Esthetics-USA Spa training which has changed the lives of thousands of aestheticians and their clients.
The scholarship includes a three-day immersive Oncology Spa Solutions Essentials course. The course provides an overview of how cancer affects hair, skin, and nails and how aestheticians can confidently and safely ask the right questions to customize a spa treatment. “The training includes the mind, body, and spirit elements that accompany a cancer diagnoses,” says Becky Kuehn, founder and director of Oncology Spa Solutions and a cancer survivor for nearly 40 years. “Cancer patients often say that no one listens to them, but those in the spa industry know if you can listen, you have a client for life,” Kuehn says.
Scholarship applicants must submit an online application, provide proof of licensure, and submit a three- to five-minute video describing why they chose an aesthetics career and how advanced aesthetic education will benefit their career. Videos must show application of an aesthetics treatment and communicate the applicant’s passion for esthetics.
As founder of Aveda Corporation and Intelligent Nutrients, the late Horst Rechelbacher pioneered an entrepreneurial philosophy that celebrated beauty professionals as part of a sustainable evolution using products that care for professionals, their clients, and the planet. Rechelbacher was posthumously awarded the Beauty Changes Lives Legacy award in 2019.
“Horst was passionate about educating beauty professionals about the role products play in protecting both people and the planet,” said Lynelle Lynch, president of Beauty Changes Lives. The Sustainable Success and Oncology Skincare scholarships are generously paying his passion and success forward to a new generation of hairstylists and aestheticians.”
Almirall, S.A. announced that a key milestone under the collaboration with Nuevolution has been achieved. The strategic collaboration was entered on December 12, 2016 with the aim to develop innovative RORγt inhibitors with best-in-class potential for the oral and topical treatment of dermatology diseases and psoriatic arthritis. A significant part of the collaboration work has been to evaluate pre-clinical safety parameters of RORγt inhibition and to comprehensively de-risk the program prior to any human testing. The milestone data achieved supports a program with a Candidate Drug (CD) having best-in-class potential.
The program continues its progression towards clinical development. The positive result triggered a contractual milestone to Nuevolution.
Bhushan Hardas, M.D., MBA, chief scientific officer of Almirall, commented, “We are very pleased with the progress achieved in our strategic collaboration with Nuevolution, which reflects Almirall’s commitment to becoming a leader in medical dermatology by reinforcing our pipeline with true innovative best in class solutions.”
Alex H. Gouliaev, Ph.D., chief executive officer of Nuevolution, commented, “This underscores the positive opportunities for this unique program. The program development has benefitted significantly from much synergy between and dedication by the teams.”
Almirall had one of the highest levels of research and development investments in the Spanish pharmaceutical industry in 2018, representing over 12 percent of net sales. In addition, Almirall invests in assets, strategic partnerships, and collaborations in research.
Sienna Biopharmaceuticals, Inc. a clinical-stage biotechnology company, announced positive topline results from its pivotal trial of SNA-001 in conjunction with an 810 nanometers diode laser, involving 65 patients. SNA-001, a topical pre-treatment to standard laser hair removal, was studied in women and men with white, gray, blonde, light red, and light brown hair. The data showed SNA-001 met the primary endpoint of non-inferiority in hair reduction (-17.5 percent with SNA-001 plus laser, compared to -1.1 percent with vehicle plus laser following six treatment sessions). In additional analyses, SNA-001 was statistically superior compared to vehicle plus laser, demonstrating up to a 31 percent reduction of light hair from baseline.
“SNA-001 represents an exciting growth opportunity for the aesthetics market and a potential solution for consumers with light hair who are well aware of the ineffectiveness of laser hair removal,” said Frederick C. Beddingfield III, M.D., Ph.D., president and chief executive officer of Sienna Biopharmaceuticals. “We are pleased with these results and will seek a strategic partner who can rapidly maximize the value of SNA-001. This will allow us to remain focused on our phase three development of SNA-120, our TrkA inhibitor for psoriasis and pruritus, and to unlock the full potential of our Topical by Design platform, from which we are creating a pipeline of drug candidates that target select pathways in specific tissues to treat a variety of chronic inflammatory and immunologic conditions.”
Available for nearly 25 years, laser hair removal is one of the most commonly performed aesthetic procedures in the world. With more than 12 million procedures performed annually in the United States, countless patients have benefitted from the lasting results, except for those with light hair. Of the 53 million people who use laser treatments, waxing, and other methods to remove unwanted hair, one in three are light haired. People with white, gray, blonde, and red hair – for whom lasers are ineffective – have been limited to using waxing and razors to remove their unwanted light hair, which yield temporary results and, in the case of waxing, can be costly to maintain. Market data indicate that a safe and effective treatment for people with light hair could increase the number of laser hair removal procedures by 27 percent in the United States.
“This represents the first breakthrough in laser hair removal in over a decade,” said Mathew Avram, M.D., J.D., director at Massachusetts General Hospital Laser and cosmetics and dermatologic surgery associate professor at Harvard Medical School. “Sienna’s silver photo particle technology, combined with the lasers we already have in our offices, showed a meaningful reduction in light hair – something we have never achieved before. If cleared by FDA, SNA-001 would allow physicians and aesthetic centers to expand their current practices by bringing in new patients with blonde, gray, white, light brown, or light red hair who have resorted to waxing and shaving. Once available, I would anticipate rapid and widespread adoption of SNA-001.”
SNA-001 was also evaluated in conjunction with a 1064 Nd:YAG and 755 nm Alexandrite laser for the reduction of light hair, showing a significant reduction from baseline and providing a potential path to regulatory clearance. These results, however, were less differentiated from the vehicle plus laser group compared to the 810 nanometer diode laser study results.
A third and final pivotal trial of SNA-001 in acne was also completed, demonstrating SNA-001 was non-inferior to laser therapy and providing a potential path to regulatory clearance.
March 4, 2019, Bill TX HB 1705, a bill regarding “abolishing the regulation of the practices of barbering and cosmetology,” was presented to the Texas House Committee, who approved the bill and passed it on to the Texas House Licensing and Administrative Procedures Committee for review.1
Initially introduced on February 12, 2019 by Texas House representative Matthew Shaheen, the bill proposes four main points:
The main reason for Bill TX HB 1705 appears to be to make entry into these professions easier, with the hopes of increasing competition and decreasing consumer cost. However, deregulation would come with a multitude of repercussions for the industry – primarily consumer safety. No standards for education or training means putting consumers at high risk of communicable diseases and injury. Regulations ensure knowledge and practice of proper safety and sanitation protocols, as well as requirements for education on anatomy and physiology of the hair, skin, nails, and so forth. Codes and disciplinary boards keep consumers safe by enforcing such standards and issuing penalties when malpractice occurs.
1 “TX HB1705 | 2019-2020 | 86th Legislature.” LEGISCAN. https://legiscan.com/TX/bill/HB1705/2019.
2 “TX HB1705 | 2019-2020 | 86th Legislature | Introduced.” LEGISCAN. https://legiscan.com/TX/text/HB1705/2019
3 “Say No To HB 1705 - Texas Barber and Cosmetology Abolishment :Signature Goal 100K.” change.org.
4 “Find Your Representative.” United States House of Representatives. https://www.house.gov/representatives/find-your-representative?fbclid=IwAR3-EIYb4d25Y dV94vnY5C57rBJfXf-JdoqXZZW-yIJZe8_lEhqGNbFD5cg.
5 “Texas House Member.” Texas House of Representatives. https://house.texas.gov/members/member-page/?district=66&fbclid=IwAR3MMxkayQcDsoGz5AcYpXeEcJiVmaJTUzvZHDA4_BegyO6sqm_c7JX0Ghk.
The winning streak continues for natural product manufacturer, Body Bliss. For the past five years, Body Bliss has been the recipient of multiple Spa & Wellness Mexi-Caribe Product Awards. This year their new facial line, Vibrant Beauty, was honored with two awards for their Active Charcoal Face Mask, which won for best deep cleansing mask and their Illuminating Serum, which won for best brightening serum. They have formulated a skin care line that synergistically works with the intelligence of skin’s healing properties to naturally encourage a beautiful complexion. Vibrant Beauty blends the best of Body Bliss signature botanicals like prickly pear, pomegranate, and sea buckthorn with the latest cosmetic ingredients, such as niacinamide, DMAE, teprenone, argireline, and collageneer. The ingredients in the Vibrant Beauty facial line are naturally-derived and eco-friendly.
“The Body Bliss team is thrilled that Vibrant Beauty was recognized with these awards,” says Pam Sculthorp, CEO of Body Bliss. “This facial line is the first initiative we have launched since I took the helm in 2016. Our clients have been asking for skin care products for years. Vibrant Beauty balances the best in science with the most carefully-curated, botanical ingredients. The products not only make you look and feel good, but are also good for you.”